- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 182.55M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 185.76M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 106.74M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $50M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $8M |
| Capex | Q1 2026 · Mar 31, 2026 | $8M |
| Capex | Q1 2026 · Mar 31, 2025 | $6M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$95M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$16M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $116M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $164M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.14B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.23B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $929M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $974M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.78B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.69B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.25B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.28B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.93B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $3.92B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.24 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $0.19 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.24 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $0.19 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $243M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $109M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$44M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $21M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$50M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $29M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $193M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $138M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $990M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $461M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.18B |
| Revenue | Q1 2026 · Mar 31, 2025 | $599M |